Cannabis Law Report

JULY 6, 2021

David Bradley, Chief Executive of South London and Maudsley NHS Foundation Trust, said, “We believe this collaboration could accelerate much-needed research that will translate into evidence-based and direct patient care for people who use our services. London, UK – 5 July 2021. George Goldsmith, CEO and Co?founder,

Research and Development 76

Research and Development Clinical Trials Therapy Patients 76

Greencamp

APRIL 23, 2019

Canada is one of the countries with the highest numbers of MS patients. For patients who don’t respond well to conventional MS methods, cannabis treatment seems like a very reasonable choice. However, not all patients respond to these treatments well enough, and some don’t respond at all.

Research and Development 94

Research and Development Strains Patients Treatment 94

The Cannigma

MARCH 25, 2021

The problem is that marijuuana falls into this sort of gray area of being a quasi-recognized medical treatment,” Sterling said, “and you have many parole officers, police officers, judges, making independent determinations about the validity of this.”. An ideological issue for law enforcement.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Cannabis as a palliative aid for HIV patients. What is HIV and how is it manifested? How classical pharmaceuticals fight HIV.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Alchimia

MARCH 16, 2016

Once the disease starts affecting the person, life expectancy greatly depends on patients (from 3 to 20 years), with an average of 8,5 years. Patient associations estimate that we’ll have around 1,5 million people suffering from Alzheimer in Spain by 2050. Cannabis patient. Source: Spanish Society of Neurology ).

Cannabinoids 76

Cannabinoids Research and Development Treatment Patients 76

Puff Puff Post

FEBRUARY 4, 2019

Kicking any addiction requires discipline, patience and a willingness to follow a treatment plan — something that doesn’t come easily to many young people, experts said. in 2007, e-cigarettes and other vaping devices have grown into a $6.6 But we desperately need studies to figure out what’s going to work with this population.”.

Vaping 101

Vaping Therapy Programs Advocacy 101

Cannabis Law Report

OCTOBER 1, 2019

“Among these changes was a change to the definition of a qualified patient,” Marissa Novel, chief marketing officer for Ultra Health , one of the state’s licensed vertically integrated cannabis businesses, told Cannabis Business Times. “In But not so fast. Then the lawsuit landed in Biedscheid’s courtroom.

Programs 59

Programs Patients Conditions Legislation 59

Medicinal Marijuana Association

NOVEMBER 17, 2021

Is cannabis a possible treatment for cerebral palsy symptoms? Patients with cerebral palsy exhibit abnormal movement, muscle tone, or posture because of their neurological disorder. There is currently no cure for the disease, but scientists are looking for treatments to relieve symptoms. One such treatment is medical marijuana.

Treatment 52

Treatment Conditions Cannabis THC 52

Cannabis Law Report

FEBRUARY 25, 2022

Ultra Health, one of the state’s largest medical cannabis producers, which had filed the original lawsuits, had not been charging patients taxes, and instead had been absorbing the taxes. The company said that it would receive a $7.4 million refund plus interest following the Supreme Court ruling. “It

Programs 52

Programs Collective Data Patients 52

Cannabis Law Report

MARCH 10, 2022

AP) — The New Mexico Supreme Court has last stand a lower court ruling that found cannabis purchases by medical marijuana patients should not be subject to gross receipts tax. New Mexico established its medical marijuana program in 2007 and growth in recent years has been significant, with more than 130,340 patients enrolled as of January.

Access 52

Access Collective Patients Treatment 52

The Cannigma

AUGUST 26, 2021

This represents nearly double the level of support found in a 2007 survey (21%). The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Veriheal

FEBRUARY 28, 2021

The last day of February, the 28th, or the 29th during a leap year is World Rare Disease Day and this day has been designated to help bring awareness to rare diseases as well as the impact they have on patients and their lives. When it comes to rare diseases and their treatment options, there are very few.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

Freedom Leaf

JANUARY 10, 2018

Tikun Olam , which was founded in 2007, controls nearly 40% of the Israeli medical-marijuana market. Under the Israeli program, patients must commit to a single cannabis producer. Hence, companies like Tikun Olam are able to find out exactly what their patients need based on their ailments, and create medicine accordingly.

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

CannaMD

JULY 21, 2020

Hundreds of thousands of patients in the Treasure Coast area are catching on, according to local news reports. As a potential treatment for “chronic non-malignant pain.” Marijuana has been used as medicine since 2,900 B.C., less inflamed!) Their largest reason for seeking medical marijuana? Find Out if You Qualify.

Chronic Pain 52

Chronic Pain Marijuana Cannabinoids Medicine 52

The Cannigma

OCTOBER 8, 2021

The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients. The first medical cannabis patients in Scotland received their prescriptions in 2021 , and the country’s first medical cannabis clinic was approved in March, 2021.

Legalization 52

Legalization Medicine Conditions Patients 52

Canna Care Docs

JULY 29, 2019

Compared with the 2006-2007 survey, the increases are 100% for 50- to 64-year-olds and 625% for 65 or older. She said about 24%, nearly one out of four, of their patients are ages 60 to 74, and another 10% are over 75. of people in their 50s, or nearly one in five residents in that age group; 14.1% of people in their 60s; and 3.4%

Chronic Pain 53

Chronic Pain Sleep Education Patients 53

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Green Relief

FEBRUARY 20, 2018

Using genetic information to formulate a unique cannabis blend can decrease the “trial and error” phase upon starting cannabis, and provide more consistency in improving patient outcomes. Assessing an individual’s genetics specific to the Endocannabinoid System (including other system pathways that overlap) helps to guide cannabis therapy.

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Corante

FEBRUARY 26, 2020

In 2007, the first medical marijuana testing lab, located in Oakland , determined that the THC content of the products they were testing was about 15% while less than 2% of samples contained 4% CBD. Though these growers understood that their cannabis crops were unique, many did not fully understand what set them apart from others.

Strains 40

Strains CBD Hemp THC 40

Green Relief

FEBRUARY 19, 2018

Using genetic information to formulate a unique cannabis blend can decrease the “trial and error” phase upon starting cannabis, and provide more consistency in improving patient outcomes. Assessing an individual’s genetics specific to the Endocannabinoid System (including other system pathways that overlap) helps to guide cannabis therapy.

Therapy 40

Therapy Cannabinoids Terpenes Pharmaceutical 40

Greenspoon Marder Cannabis Law Group Blog

JUNE 25, 2021

The Tax Court in Patients Mutual [15] Assistance Collective Coop. Moreover, as a result of the enactment of what is commonly referred to as the Tax Cuts and Jobs Act of 2017 (the “Act”), the treatment of income derived by foreign affiliates of U.S. 173, 182 (2007). [11] 11] Patients Mutual Assistance Collective Coop.

Business 72

Business Cannabis Seed-To-Sale Law 72

Cannabis Law Report

JUNE 11, 2019

Just because another case finds marihuana useful for one patient does not automatically infer that it is medically necessary for another plaintiff. Compensation is not payable for treatments that “simply improve the plaintiff’s enjoyment of life” 32. Concluding Comments.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Otherside Farms

JANUARY 23, 2019

1-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus (full – 1974). abst – 2007). 2007 (1): 4749 — AACR Meeting Abstracts. abst – 2007). Marijuana Cuts Lung Cancer Tumor Growth In Half, Study Shows (news – 2007). news -2007). 3, September 1975, pp.597-602).

Oil 75

Oil Cannabinoids Medicine Treatment 75

Otherside Farms

JANUARY 23, 2019

Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. full – 2007). Cannabis compound cannabidiol CBD ‘halts cancer’ & may bring relive to other illness’s (news – 2007). news – 2007).

Cannabinoids 72

Cannabinoids Treatment Therapy Research and Development 72

United Patients Group

APRIL 18, 2023

The truth is that it’s impossible to fatally overdose on marijuana alone, as a study in the American Journal of Public Health found no deaths reported due to cannabis use between 1999 and 2007. In fact, there are some patients who prefer not to smoke because of their health conditions or other reasons. Myth: One size fits all.

Research and Development 116

Research and Development Indica Treatment Conditions 116

Cannabis Law Report

JANUARY 23, 2022

At current, transplant treatments are hindered by our understanding of the immune response of those receiving treatments. More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-de?ciency Many variables impact the outcomes of GVHD. Implications.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Kind Meds (Cannabis Education Blog)

APRIL 25, 2022

The first known use of marijuana to treat medical conditions within patients was cited in China in the third millennium BCE. Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. 2] Tambaro, S., & Bortolato, M. 3] Aggarwal, S. 3] Aggarwal, S. ↑ 3 Aggarwal, S.

Strains 98

Strains Marijuana Sativa Hybrid 98

Greencamp

NOVEMBER 9, 2018

In this article we’ll investigate the science behind using cannabis with asthma, patients’ experiences with the plant and the best methods to get medicated if you’re suffering from asthma. Sadly, there is no permanent cure for this condition, but there are a few types of treatments to keep it under control.

Research and Development 92

Research and Development Edibles Patients Cannabinoids 92

Cannabis Law Report

JULY 16, 2019

Within months he realized he was going to have to grow his own cannabis to cut down on the cost of treatment. In July, 2012, he and his wife settled in south Redding, where, at the time, the outdoor cultivation of medical cannabis was legal for qualified patients. Colorado was too expensive, Oregon had too many regulations.

Patients 40

Patients Cultivation Cannabis Strains 40

Greencamp

DECEMBER 4, 2018

This is why CBD works wonders for anxiety ( 4 ) and also PTSD patients. For the purpose of this guide we’ve collaborated with Dr. Dustin Sulak who is one of the top-tier cannabis physicians in the US and has extensive experience with treating patients with medical cannabis. Depression. Post-traumatic Stress Disorder (PTSD).

Cannabinoids 107

Cannabinoids Research and Development Conditions THC 107

Cannabis Law Report

JANUARY 5, 2020

Also, the state allowed medical marijuana for certain medical conditions in 2007. As a cancer patient, New Mexico resident Lynn Pierson found cannabis useful and appealed to the state government to allow him to use cannabis. New Mexico legalized medical cannabis in 2007 by approving the Lynn and Erin Compassionate Use Act.

Law 49

Law Decriminalization Recreational Patients 49

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

OCTOBER 29, 2019

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Dogs received each of two treatments: CBD oil (2 mg/kg) or placebo oil every 12 h. Each treatment lasted for 4 weeks with a 2-week washout period. Veterinary assessment showed decreased pain during CBD treatment ( p < 0.02).

Safety 45

Safety CBD Clinical Trials Oil 45

Veriheal

JUNE 13, 2023

Chronic obstructive pulmonary disease, or COPD, was short is a pulmonary condition in which patients experience persistent coughing and shortness of breath. While this condition cannot be cured, there are some treatments to help reduce its impact on patients’ day-to-day lives.

Research and Development 98

Research and Development Treatment Retail Conditions 98

Cannabis Law Report

JANUARY 7, 2020

During the years at issue, California law provided an exemption from California laws penalizing the possession and cultivation of marijuana for patients and their primary caregivers when the possession or cultivation was for the patient’s personal medical purposes and was recommended or approved by a physician. The Golden State.

Business 66

Business Marijuana Seed-To-Sale Patients 66

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). Case Context.

DEA 52

DEA Clinical Trials Policy Research and Development 52